Search research articles
Contact Us
Filters
Showing results (1-10 of 167) with videos related to
Page
of 17
Sort By:
Antimicrobial Agents and Chemotherapy
|
June 13, 2023
Case Commentary: When Voldemort Meets Sauron: Treatment Considerations for Emerging Dual-Carbapenemase-Producing Extensively Drug-Resistant Pseudomonas aeruginosa
Walaiporn Wangchinda, Jason M Pogue
The Annals of Pharmacotherapy
|
September 6, 2012
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial
Cesar Alaniz, Jason M Pogue
Expert Opinion on Pharmacotherapy
|
September 10, 2019
Laces out Dan! The role of tazobactam based combinations for invasive ESBL infections in a post-MERINO world
Jason M Pogue, Emily L Heil
Pharmacotherapy
|
October 27, 2015
Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management
Keith S Kaye, Jason M Pogue
Journal of Clinical Microbiology
|
March 28, 2020
The Clinical Impact of a Negative Molecular β-Lactamase Gene Test for <i>Enterobacteriaceae</i>: Let's Not Let Perfect Be the Enemy of Really Good
Jason M Pogue, Emily L Heil
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 29, 2025
The Antibiotic Pipeline Has Delivered for Drug-Resistant Gram-Negative Pathogens, Now Global Access Must Follow
Jason M Pogue, David van Duin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2025
Actually, it may be time to return to colistin and meropenem in some patients infected with Carbapenem-resistant A. baumannii (CRAB)
Jason M Pogue, Keith S Kaye
Advances in Experimental Medicine and Biology
|
August 1, 2019
Toxicity in Patients
Jason M Pogue, Vincent H Tam
Expert Review of Anti-Infective Therapy
|
September 24, 2013
Is there really no benefit to combination therapy with colistin?
Jason M Pogue, Keith S Kaye
Open Forum Infectious Diseases
|
April 15, 2020
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
Erin K McCreary, Jason M Pogue
Page
of 17
Search research articles
Search
Showing results (1-10 of 167) with videos related to
Sort By:
Page
of 17
Antimicrobial Agents and Chemotherapy
|
June 13, 2023
Case Commentary: When Voldemort Meets Sauron: Treatment Considerations for Emerging Dual-Carbapenemase-Producing Extensively Drug-Resistant Pseudomonas aeruginosa
Walaiporn Wangchinda, Jason M Pogue
The Annals of Pharmacotherapy
|
September 6, 2012
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial
Cesar Alaniz, Jason M Pogue
Expert Opinion on Pharmacotherapy
|
September 10, 2019
Laces out Dan! The role of tazobactam based combinations for invasive ESBL infections in a post-MERINO world
Jason M Pogue, Emily L Heil
Pharmacotherapy
|
October 27, 2015
Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management
Keith S Kaye, Jason M Pogue
Journal of Clinical Microbiology
|
March 28, 2020
The Clinical Impact of a Negative Molecular β-Lactamase Gene Test for <i>Enterobacteriaceae</i>: Let's Not Let Perfect Be the Enemy of Really Good
Jason M Pogue, Emily L Heil
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 29, 2025
The Antibiotic Pipeline Has Delivered for Drug-Resistant Gram-Negative Pathogens, Now Global Access Must Follow
Jason M Pogue, David van Duin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2025
Actually, it may be time to return to colistin and meropenem in some patients infected with Carbapenem-resistant A. baumannii (CRAB)
Jason M Pogue, Keith S Kaye
Advances in Experimental Medicine and Biology
|
August 1, 2019
Toxicity in Patients
Jason M Pogue, Vincent H Tam
Expert Review of Anti-Infective Therapy
|
September 24, 2013
Is there really no benefit to combination therapy with colistin?
Jason M Pogue, Keith S Kaye
Open Forum Infectious Diseases
|
April 15, 2020
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
Erin K McCreary, Jason M Pogue
Page
of 17